White Papers
Drug Discovery World
Phenotypic Drug Discovery With High Content Screening

Today’s drug discovery strategies require candidate compounds to fail early and cheaply in the discovery stage, rather than late and expensively in the clinical phase. This white paper explains why phenotypic and target-based approaches are being combined, some challenges of phenotypic assays, and how to maximize the return on your phenotypic assays.

Click Here To Download The White Paper

To read the white paper you will be asked to fill out a very brief registration form and those details will be used by the ‘sponsor’s’ own internal marketing and sales department.

Sponsored by PerkinElmer